• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment

Patent holdings for IPC class A61K 47/68

Total number of patents in this class: 11690

10-year publication summary

378
567
989
1225
1203
1426
1485
1566
1546
706
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
SeaGen Inc
578
248
Daiichi Sankyo Company, Limited
1849
197
Regeneron Pharmaceuticals, Inc.
4211
197
Genentech, Inc.
3935
194
MedImmune Limited
607
149
Hanmi Pharm. Co., Ltd.
568
148
ImmunoGen, Inc.
398
130
Dyne Therapeutics, Inc.
236
125
The Regents of the University of California
19784
114
Novartis AG
10963
91
Bristol-myers Squibb Company
4896
90
Bolt Biotherapeutics, Inc.
119
90
Pfizer Inc.
3352
76
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
278
65
ADC Therapeutics SA
124
63
Hoffmann-La Roche Inc.
3357
60
Memorial Sloan-Kettering Cancer Center
1901
59
CytomX Therapeutics, Inc.
215
58
Hangzhou DAC Biotech Co., Ltd
102
58
Immunomedics, Inc.
267
58
Other owners 9420